29.05.2020 BE law Stibbe assists Avista Capital Partners Experience - Stibbe assisted Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Read more Team: Dries Hommez, Hans Witteveen, Wouter Ghijsels, Michael Molenaars, Henk Verstraete, Pieter-Jan Leemen, Margaux Beyer, Sebastiaan Witkam, Britt Vanderschrick, Nina Coussement, Esther Everaert
24.04.2020 BE law Stibbe assists LDA Capital Experience - Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Read more Team: Jan Peeters, Liselot Claeys
06.11.2019 NL law Stibbe advises Wright Medical Group Experience - Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. Read more Team: Duco de Boer, Jeroen Smits, Eva Das, Manon Cremers, Pieter Schütte, Dennis Mollema, Tom Storck, Claire-Marie Darnand
26.06.2019 BE law Stibbe advises DW Healthcare Partners Experience - Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Read more Team: Gérald Origer, Julien Bogaerts, Jérôme Aubertin, Jean-Marc Delcour, Michaël Meylan, Steven Paridaens, Raphaël Delsaux, Joanna De Smedt, Giada Mognol
14.12.2018 NL law Stibbe advises Aedifica Experience - Stibbe advised Aedifica on the acquisition of a healthcare residence for the elderly in Franeker (Friesland). Read more Team: Maarten de Bruin, Boris Cammelbeeck, Jan van Oosten, Ashley Peeters, Eloïse Spoelman, Jake Tingen
08.10.2018 NL law Stibbe advises Aedifica Experience - Stibbe advises Aedifica on the acquisition of three healthcare residences for the elderly at Leiden, Oss and Amersfoort. The three residences are operated by ECR/Blueprint Group. Read more Team: Maarten de Bruin, Edsart van Wulfften Palthe
10.09.2018 NL law Stibbe advises on the equity offering of ProQR Experience - Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). Read more Team: Pieter Schütte, Jeroen Smits, Lotte Hover-Boon, Emilie Renardel de Lavalette
26.07.2018 NL law Stibbe advises Agendia Experience - Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management. Read more Team: Pieter Schütte, Samuel Gray, Rein van Helden, Manon Cremers, Fons Leijten, Suzanne van Boheemen, Eline Holtman, Rik van Kessel, Emilie Renardel de Lavalette
12.04.2018 NL law Stibbe advises SleepScore Labs Experience - Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Read more Team: Heleen Kersten, Reinout de Boer, Ea Visser
29.03.2018 NL law Stibbe advises Lundbeck Experience - Stibbe advised Lundbeck on the acquisition of Prexton Therapeutics BV for an amount of up to EUR 905 million. Read more Dennis Mollema Senior Associate Amsterdam
08.03.2018 NL law Stibbe advises Canon Medical Systems Experience - Stibbe advised Canon Medical Systems on the acquisition of Dutch medical equipment manufacturer Fysicon. Read more Team: Reinout de Boer, Sophie Zwartkruis-Bakker, Dennis Mollema, Boris Cammelbeeck, Ea Visser
15.11.2017 NL law Stibbe advises Aedifica Experience - Stibbe advises Aedifica on the acquisition of a care residence to be constructed in Bosch en Duin (municipality of Zeist). Read more Team: Maarten de Bruin, Jan van Oosten
18.02.2021 BE law Philippe Campolini is a panelist during a webinar organised by EPLAW Seminar - Philippe Campolini, partner in our IP department and board member of EPLAW (the European Patent Lawyers Association), is panelist during a webinar on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Read more Philippe Campolini Partner Brussels
14.07.2020 EU law Breaking news from the CJEU: no SPCs for new therapeutic applications Short Reads - On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. Read more Team: Philippe Campolini, Ignace Vernimme, Manuel Campolini, Louis Bidaine
11.03.2020 NL law Jeroen Kortmann nominated for best Dutch litigator Inside Stibbe - For the second consecutive year, Jeroen Kortmann has been nominated for the title of 'best Dutch litigator'. Read more Jeroen Kortmann Partner Amsterdam
28.02.2020 NL law Dutch chapter to Chambers Global Practice Guides Corporate Tax 2020 Articles - A tax team of Stibbe has contributed the Dutch chapter of Chambers Global Practice Guides Corporate Tax 2020. Read more Team: Michael Molenaars, Jeroen Smits, Reinout de Boer, Rogier van der Struijk
03.11.2020 BE law Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Articles - Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Read more Team: Philippe Campolini, Ignace Vernimme, Peter Wytinck, Sophie Van Besien
30.03.2020 BE law Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures Short Reads - The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Read more Team: Jan Bouckaert, Bastiaan Schelstraete, Maarten Christiaens
11.03.2020 NL law The Dutch scheme – when can it be used, and by whom? Short Reads - As mentioned in our earlier blog, the Dutch legislator has prepared a bill – the Act on confirmation of private restructuring plans (Wet homologatie onderhands akkoord) – which introduces a framework allowing debtors to restructure their debts outside formal insolvency proceedings (the “Dutch Scheme“). Read more Team: Job van Hooff, Daisy Nijkamp, Bram Berends
21.02.2020 NL law De informatiewaarde van het verslag van de raad van commissarissen Articles - In dit artikel doen Steven Hijink, Sandra Rietveld, Lars in ’t Veld en Erick Noorloos (KPN) verslag van een drietal praktijkonderzoeken naar de jaarverslagen van Nederlandse beursvennootschappen over 2018. Read more Team: Steven Hijink, Sandra Rietveld, Lars in 't Veld
25.09.2020 BE law Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Articles - Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Read more Team: Ignace Vernimme, Philippe Campolini
23.03.2020 BE law Contracts & Corona: force majeure and related topics Short Reads - The spread of the coronavirus may have some consequences that affect your ability to perform your obligations under your contracts, or your co-contractors’ ability to perform theirs. We provide some insight on a few pressing questions. Read more Team: Oliver Stevens, Tobe Inghelbrecht
10.03.2020 NL law De AVG staat niet in de weg aan de verwerking van persoonsgegevens door een toezichthouder tijdens een bedrijfsbezoek Short Reads - Bedrijven die met toezicht worden geconfronteerd, zijn gehouden op verzoek van een toezichthouder in beginsel alle informatie te verstrekken. Met de komst van de Algemene verordening gegevensbescherming (AVG) is in de praktijk de vraag opgekomen of een toezichthouder bevoegd is om persoonsgegevens die onderdeel uitmaken van de gevraagde informatie te verwerken. Read more Christien Saris Senior Associate Amsterdam
05.02.2020 NL law De informatiewaarde en toekomstbestendigheid van jaarlijkse verslaggeving Articles - Traditioneel aan het einde van het (boek)jaar maken veel beursvennootschappen zich op voor het jaarlijkse seizoen van algemene vergaderingen. Dat houdt onder meer in dat beursvennootschappen voorbereidingen moeten treffen voor het opstellen van de jaarlijkse verslaggeving. De (publicatie van de) jaarlijkse verslaggeving is een van de wijzen waarop het bestuur en de raad van commissarissen van de beursvennootschap rekening en verantwoording afleggen over, c.q. verslag doen van, de wijze waarop zij zich van hun respectieve taken en verantwoordelijkheden hebben gekweten. Read more Team: Steven Hijink, Lars in 't Veld